A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the global push towards making leprosy history. The five-year extension of the partnership – which was first signed in 2000 – will see Novartis continue to donate multidrug therapy (MDT) medicines to treat leprosy up to the end of 2025.
In response to the disproportionate and devastating impact COVID-19 has had on Black communities and other underserved communities of color, the first of hundreds of COVID-19 testing, vaccine awareness and education events nationwide took place at the historic Abyssinian Baptist Church in Harlem, January 25th.